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Curcumin suppresses the production of 
interleukin-6 in Prevotella intermedia 
lipopolysaccharide-activated RAW 264.7 cells
Sung-Jo Kim
*
Department of Periodontology, Pusan National University School of Dentistry, Yangsan, Korea
Purpose: Curcumin is known to exert numerous biological effects including anti-inflammatory activity. In this study, we in-
vestigated the effects of curcumin on the production of interleukin-6 (IL-6) by murine macrophage-like RAW 264.7 cells stim-
ulated with lipopolysaccharide (LPS) from Prevotella intermedia, a major cause of inflammatory periodontal disease, and 
sought to determine the underlying mechanisms of action.
Methods: LPS was prepared from lyophilized P. intermedia ATCC 25611 cells by the standard hot phenol-water method. Cul-
ture supernatants were collected and assayed for IL-6. We used real-time polymerase chain reaction to detect IL-6 mRNA ex-
pression. IκB-α degradation, nuclear translocation of NF-κB subunits, and STAT1 phosphorylation were characterized via im-
munoblotting. DNA-binding of NF-κB was also analyzed.
Results: Curcumin strongly suppressed the production of IL-6 at both gene transcription and translation levels in P. interme-
dia LPS-activated RAW 264.7 cells. Curcumin did not inhibit the degradation of IκB-α induced by P. intermedia LPS. Curcumin 
blocked NF-κB signaling through the inhibition of nuclear translocation of NF-κB p50 subunit. Curcumin also attenuated 
DNA binding activity of p50 and p65 subunits and suppressed STAT1 phosphorylation.
Conclusions: Although further study is required to explore the detailed mechanism of action, curcumin may contribute to 
blockade of the host-destructive processes mediated by IL-6 and appears to have potential therapeutic values in the treatment 
of inflammatory periodontal disease.
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INTRODUCTION 
Curcumin is a major phenolic compound found in the 
spice turmeric [1]. This compound has been shown to pos-
sess a wide spectrum of potential biological benefits, includ-
ing antioxidant, anti-tumor, cardio-protective, antibacterial, 
antiviral, and anti-inflammatory properties [2-5]. Thus, cur-
cumin has a potential therapeutic value against various 
chronic diseases, including allergies, rheumatoid arthritis, 
diabetes, cardiovascular diseases, cancer, and other chronic 
illnesses.
Periodontal disease is a chronic inflammatory process ac-
companied by destruction of surrounding connective tissue 
and alveolar bone, and sometimes loss of teeth [6]. The pri-
mary causative agents of periodontal disease are particular 
gram-negative anaerobic bacteria that accumulate in the 
gingival sulcus. Prevotella intermedia is a major periodontal 
pathogen that is dominant in the subgingival flora of pa-
tients with adult periodontitis [7,8], acute necrotizing ulcer-
ative gingivitis [9], and pregnancy gingivitis [10].
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Lipopolysaccharide (LPS) is a major component of the outer 
membrane of gram-negative bacteria, including P. interme-
dia. It can trigger a number of host cells to produce and re-
lease a wide variety of proinflammatory cytokines, including 
tumor necrosis factor alpha (TNF-α), IL-1β, IL-6, and IL-8 [11]. 
LPS preparations extracted from oral black-pigmented bacte-
ria including P. intermedia have been reported to possess 
unique chemical and immunobiological properties quite dif-
ferent from those of the classical LPSs from the family En-
terobacteriaceae such as Escherichia coli and Salmonella species 
[12-14].
Host responses to the specific causative bacteria and their 
metabolic products are a major determinant of disease patho-
genesis. Recent work has demonstrated, in addition to bacte-
rial control, that modulation of the host inflammatory re-
sponse is a plausible therapeutic strategy for periodontal dis-
ease [15,16]. Therefore, host modulatory agents directed at in-
hibiting specific cytokines appear to be beneficial in terms of 
attenuating periodontal disease progression and potentially 
enhancing therapeutic responses. Therefore, in the present 
study we investigated the effects of curcumin on the produc-
tion of IL-6 by macrophages stimulated with LPS from P. in-
termedia and sought to determine the underlying mecha-
nisms of action.
MATERIALS AND METHODS
Reagents
Curcumin was obtained from Sigma-Aldrich (St. Louis, MO, 
USA). Antibodies against IκB-α, STAT1 and phospho-STAT1 
were obtained from Cell Signaling Technology (Beverly, MA, 
USA), while antibodies against NF-κB p65, NF-κB p50, and 
PARP-1 were purchased from Santa Cruz Biotechnology 
(Santa Cruz, CA, USA).
Bacteria and culture conditions
P. intermedia ATCC 25611 was used throughout. It was grown 
anaerobically on the surface of enriched Trypticase soy agar 
containing 5% (v/v) sheep blood, or in general anaerobic me-
dium broth (Nissui, Tokyo, Japan) supplemented with 1 μg/
mL menadione and 5 μg/mL hemin. Culture purity was as-
sessed by gram staining and plating on solid medium.
LPS isolation
LPS was prepared from lyophilized P. intermedia ATCC 25611 
cells by the standard hot phenol-water method as described 
previously [17]. The protein content of the purified LPS was 
less than 0.1%. Coomassie blue staining of overloaded sodi-
um dodecyl sulfate (SDS)-polyacrylamide gels did not reveal 
any visible protein bands in the purified LPS, confirming the 
purity of the preparation (data not shown).
Cell cultures 
The murine macrophage cell line RAW 264.7 (American 
Type Culture Collection, Rockville, MD, USA) was in Dulbec-
co’s modified Eagle’s medium as described previously [17]. 
The cells were seeded into 24-well culture plates at a density 
of 5×10
5 cells/well and incubated for at least 12 hours to allow 
them to adhere to the plates. After washing three times with 
medium, various concentrations of P. intermedia LPS and cur-
cumin were added and the cells were cultured for 24 hours, 
after which culture supernatants were collected and assayed 
for IL-6. 
Cytotoxicity assay
The cellular toxicity of curcumin was assessed by the MTT 
assay. Cells were incubated with various concentrations of P. 
intermedia LPS and curcumin for 24 hours, and MTT was 
added to the cultures to a final concentration of 0.5 mg/mL. 
After incubation at 37°C in 5% CO2 for 2 hours, the superna-
tant was removed and the cells were solubilized in dimethyl 
sulfoxide. The extent of reduction of MTT to formazan with-
in the cells was quantified by measuring absorbance at 570 
nm with a Spectra Max 250 ELISA Reader (Molecular Devices 
Inc., Sunnyvale, CA, USA).
Measurement of IL-6 production
The amount of IL-6 secreted into the culture medium was 
determined by enzyme-linked immunosorbent assay (ELISA) 
using a commercially available kit (OptEIA, BD Biosciences 
Pharmingen, San Diego, CA, USA) according to protocols 
recommended by the manufacturer.
RNA extraction and real-time polymerase chain reaction 
(PCR) for IL-6 mRNA
Cells were plated in 100 mm tissue culture dishes at a densi-
ty of 1×10
7 cells/dish and treated with various concentrations 
of P. intermedia LPS and curcumin for 24 hours. Total RNA was 
isolated with an RNeasy Mini Kit (Qiagen, Valencia, CA, USA) 
according to the manufacturer’s instructions. cDNA was pre-
pared from 1 μg of the total RNA using iScript cDNA Synthe-
sis Kit (Bio-Rad Laboratories Inc., Hercules, CA, USA). A real-
time PCR was performed using the CFX96 real-time PCR de-
tection system (Bio-Rad Laboratories Inc.) with a specific 
primer for mouse IL-6. As an endogenous control, β-actin 
primer was used. PCR was conducted with SsoFast EvaGreen 
Supermix (Bio-Rad Laboratories Inc.) according to the manu-
facturer’s instruction. Thermal cycler conditions were as fol-
lows: After denaturing at 98°C for 30 seconds, PCR was per-
formed for 45 cycles, each of which consisted of denaturing at Journal of Periodontal
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95°C for 1 second, annealing/extending at 60°C for 5 seconds. 
The following PCR primers for IL-6 (162 bp), and β-actin (149 
bp) were used: IL-6 sense, 5´-GCCAGAGTCCTTCAGAGAGA-
TACAG-3´ and antisense, 5´-GAATTGGATGGTCTTGGTC-
CTTAGC-3´; β-actin sense, 5´-TGAGAGGGAAATCGTGCGT-
GAC-3´ and antisense, 5´-GCTCGTTGCCAATAGTGAT-
GACC-3´. Each assay was normalized to β-actin mRNA. 
Immunoblotting analysis 
Cells were plated in 60-mm tissue culture dishes, at a den-
sity of 4×10
6 cells per dish, and treated with various concen-
trations of P. intermedia LPS and curcumin for the indicated 
periods of time. Cell lysates were prepared as described pre-
viously [17]. The nuclear fraction was prepared from cells us-
ing the ActiveMotif nuclear extract kit (Active Motif, Carlsbad, 
CA, USA) according to the manufacturer’s instructions. Pro-
tein concentrations were determined with the bicinchoninic 
acid protein assay reagents (Pierce, Rockford, IL, USA) accord-
ing to the manufacturer’s instructions. The same amount of 
protein (30 μg) was then subjected to SDS-polyacrylamide gel 
electrophoresis on 10 to 12% acrylamide gels with 3% stack-
ing gels. The resolved proteins were transferred to a nitrocel-
lulose membrane by electroblotting, and the blots were 
blocked for 1 hour in PBST (Phosphate Buffered Saline with 
0.1% Tween-20) containing 3% nonfat dry milk, followed by 
incubation with specific primary antibodies. They were then 
washed three times for 10 minutes each with PBST, incubat-
ed with horseradish peroxidase-conjugated secondary anti-
bodies at room temperature for 1 hour and visualized by en-
hanced chemiluminescence (Cell Signaling Technology) as 
recommended. 
DNA-binding activity of NF-κB
Cells were plated in 60-mm tissue culture dishes, at a den-
sity of 4×10
6 cells per dish, and incubated with curcumin (20 
μM) in the absence or presence of P. intermedia LPS (10 μg/
mL) for the indicated periods of time. After extracting the 
nuclear protein as described above, the DNA-binding activity 
of NF-κB in nuclear extract was assayed by using a TransAM 
NF-κB p65/NF-κB p50 transcription factor assay kits (Active 
Motif) according to the manufacturer’s recommended pro-
cedures. Oligonucleotide with the NF-κB consensus binding 
site (5´-GGGACTTTCC-3´), to which the activated NF-κB 
contained in nuclear extracts specifically binds, has been im-
mobilized on a 96-strip well plate. The activated NF-κB p65 
and p50 specifically bound to this oligonucleotide was de-
tected using specific antibodies to NF-κB p65 and p50, re-
spectively. A Spectra Max 250 ELISA Reader was used to read 
the sample absorbance, with results expressed as optical den-
sity emitted at 450 nm.
Statistical analysis 
Data are expressed as means±SD and statistical analysis 
was performed using Student’s t-test with P<0.05 consid-
ered statistically significant.
RESULTS
Effects of curcumin on P. intermedia LPS-induced IL-6 pro-
duction
Stimulation of RAW 264.7 cells with P. intermedia LPS in-
duced significant increases in IL-6 (Fig. 1). Curcumin inhibit-
ed IL-6 production dose-dependently in P. intermedia LPS-
treated cells. Treatment of cells with 20 μM curcumin re-
duced IL-6 production by 83%. Curcumin did not affect the 
cell viability as determined by MTT assay (data not shown), 
indicating that inhibitory effects of curcumin on IL-6 pro-
duction was unrelated to its cytotoxicity. As shown in Fig. 2, 
curcumin also reduced P. intermedia LPS-induced IL-6 mRNA 
expression in a dose-dependent manner. 
Effects of curcumin on P. intermedia LPS-induced NF-κB 
ativation
The previous study [17] showed that the NF-κB and JAK2/
STAT1 pathways are involved in IL-6 production induced by 
P. intermedia LPS. First, the effect of curcumin on P. interme-
dia LPS-induced degradation of IκB-α, upstream signaling 
pathway of NF-κB, was determined by immunoblotting. The 
degradation of IκB-α induced by LPS was not inhibited when 
cells were co-treated with curcumin (Fig. 3). Next, the effects 
of curcumin on the nuclear translocation of NF-κB subunits 
were examined. Nuclear fractions were immunoblotted with 
Figure 1. Effects of curcumin on Prevotella intermedia lipopolysac-
charide (LPS)-induced production of interleukin (IL)-6 in RAW 264.7 
cells. Cells were incubated with different doses of curcumin (0, 1, 5, 
10, and 20 μM) in the absence or presence of P. intermedia LPS (10 
μg/mL). Supernatants were removed after 24 hours and assayed for 
IL-6. The results are means±standard deviation of three indepen-
dent experiments. 
a)P<0.01 versus P. intermedia LPS alone.
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antibodies against NF-κB p65 and p50. As shown in Fig. 4A, 
curcumin did not affect P. intermedia LPS-induced p65 nucle-
ar translocation. Instead, translocation of p50 subunit was 
dose-dependently hampered in the presence of curcumin 
(Fig. 4A). Finally, DNA-binding activity of NF-κB in nuclear 
extract was analyzed by using the ELISA-based NF-κB p65/
NF-κB p50 transcription factor assay kits. DNA-binding ac-
tivities of NF-κB p65 and p50 subunits induced by P. interme-
dia LPS were attenuated by treatment with curcumin (Fig. 
4B). 
Effects of curcumin on P. intermedia LPS-induced phosphor-
ylation of STAT1
It was examined whether curcumin regulates P. intermedia 
LPS-induced IL-6 production through inhibiting the STAT1 
pathway. STAT1 phosphorylation induced by P. intermedia 
LPS was dose-dependently inhibited by curcumin (Fig. 5).
DISCUSSION
It is well known that LPSs from periodontal pathogens in-
duce excess production of inflammatory mediators, such as 
NO, TNF-α, and IL-6 in immune cells [17-20]. These proin-
flammatory mediators are potential targets for the develop-
ment of new therapeutic approaches to the treatment of peri-
odontitis, because these molecules play a significant role in 
the development of periodontal destruction.
The results of the present study indicate that curcumin sup-
presses the production of IL-6 at both gene transcription and 
translation levels in P. intermedia LPS-activated RAW 264.7 
cells. IL-6 is important in the pathogenesis of periodontal 
disease. Clinically, IL-6 levels in sites with periodontal disease 
are higher than those in healthy sites and closely related to 
the severity of periodontal disease [21,22]. Moreover, it has 
been well demonstrated that IL-6 is a potent bone resorptive 
agent, induces osteoclastogenesis, and hence plays important 
roles in alveolar bone resorption in periodontal disease [23,24]. 
Blockade of IL-6, therefore, could be a highly efficient tool for 
blocking the development and progression of inflammatory 
periodontal disease.
It is generally accepted that multiple signal transduction 
pathways participate in LPS-induced activation of macro-
phages and resultant production of proinflammatory cyto-
kines, and NF-κB pathways play critical roles. NF-κB is a 
transcription factor that plays a critical role in the expressions 
of proinflammatory cytokines and other mediators [25-28]. In 
this study, curcumin did not inhibit NF-κB transcriptional ac-
tivity at the level of IκB-α degradation. Curcumin blocked 
NF-κB signaling through inhibition of nuclear translocation 
of NF-κB p50 subunit induced with P. intermedia LPS. In ad-
dition, curcumin also attenuated DNA-binding activities of 
NF-κB p65 and p50 subunits. p50 usually forms a heterodi-
mer with other NF-κB subunits and participates in target 
gene transcription [29,30]. Inhibition of NF-κB activity by 
curcumin would be useful in the treatment of inflammatory 
periodontal disease.
The STAT signaling pathway plays an essential role in the 
regulation of inflammatory responses [31]. The seven STAT 
family members are identified in mammals, and each one 
binds to a different DNA sequence [32]. The STAT family of 
transcription factors are activated by JAKs [33,34]. STAT1, 
downstream of JAK2, appears to be an important transcrip-
tion factor for LPS-induced gene expressions in macrophages 
[35]. In this study, curcumin down-regulaed P. intermedia LPS-
induced IL-6 production via regulating the STAT1 pathway. 
Thus, the STAT1 signaling pathway could be a potential mo-
Figure 2. Effects of curcumin on Prevotella intermedia lipopolysac-
charide (LPS)-induced interleukin (IL)-6 mRNA expression in RAW 
264.7 cells. Cells were incubated with different doses of curcumin (0, 
1, 5, 10, and 20 μM) in the absence or presence of P. intermedia LPS 
(10 μg/mL) for 24 hours. Real-time polymerase chain reaction was 
performed with EvaGreen Supermix, β-actin being used as an en-
dogenous control. Data are presented as percentage of P. intermedia 
LPS alone. The results are means±standard deviation of three inde-
pendent experiments. 
a)P<0.05. 
b)P<0.01 vs. P. intermedia LPS alone.
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Figure 3. Effects of curcumin on Prevotella intermedia lipopolysac-
charide (LPS)-induced IκB-α degradation in RAW 264.7 cells. Cells 
were incubated with different doses of curcumin (0, 1, 5, 10, and 20 
μM) in the absence or presence of P. intermedia LPS (10 μg/mL). Af-
ter 30 minutes of incubation, IκB-α degradation was determined by 
immunoblot analysis of cell lysates using antibody against IκB-α. A 
representative immunoblot from two separate experiments with 
similar results is shown.Journal of Periodontal
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lecular target for treating periodontal disease.
In summary, this study shows that curcumin strongly sup-
presses IL-6 production induced by LPS from P. intermedia in 
macrophages. The underlying mechanisms of curcumin in-
volve the inhibition of NF-κB and STAT1 pathways. Although 
further study is required to explore the detailed mechanism 
of action, curcumin may contribute to blockade of the host-
destructive processes mediated by IL-6 and appears to have 
potential therapeutic values in the treatment of inflammato-
ry periodontal disease.
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Figure 4. Effects of curcumin on nuclear translocation (A) and DNA binding activity (B) of NF-κB subunits induced with Prevotella intermedia 
lipopolysaccharide (LPS) in RAW 264.7 cells. (A) Cells were incubated with different doses of curcumin (0, 1, 5, 10, and 20 μM) in the absence 
or presence of P. intermedia LPS (10 μg/mL). After 30 minutes (for NF-κB p65) or 8 hours (for NF-κB p50) of incubation, the nuclear fraction 
was isolated from cells. Nuclear translocation of NF-κB subunits was assessed by immunoblot analysis using antibodies against NF-κB p65 
and p50. A representative immunoblot from two separate experiments with similar results is shown. (B) Cells were incubated with different 
doses of curcumin (0 and 20 μM) in the absence or presence of P. intermedia LPS (10 μg/mL). After 30 minutes (for NF-κB p65) or 8 hours (for 
NF-κB p50) of incubation, DNA-binding activity of NF-κB in nuclear extracts was assessed by using the enzyme-linked immunosorbent as-
say-based NF-κB p65/NF-κB p50 transcription factor assay kits. The results are means±standard deviation of two independent experiments. 
a)P<0.05 vs. P. intermedia LPS alone. OD: optical density.
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Figure 5. Effects of curcumin on Prevotella intermedia lipopolysac-
charide (LPS)-induced phosphorylation of STAT1 in RAW 264.7 cells. 
Cells were incubated with different doses of curcumin (0, 1, 5, 10, and 
20 μM) in the absence or presence of P. intermedia LPS (10 μg/mL) 
for 4 hours. Expression of phospho-STAT1 was measured by immu-
noblot analysis of cell lysates. Total-STAT1 was used as an internal 
control. A representative immunoblot from two separate experiments 
with similar results is shown.
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